22. Multifunctional Nanoparticles for Cancer Theragnosis

  1. Xiaoyuan Chen2,3
  1. Seulki Lee,
  2. Ick Chan Kwon and
  3. Kwangmeyung Kim

Published Online: 25 MAY 2011

DOI: 10.1002/9780470767047.ch22

Nanoplatform-Based Molecular Imaging

Nanoplatform-Based Molecular Imaging

How to Cite

Lee, S., Chan Kwon, I. and Kim, K. (2011) Multifunctional Nanoparticles for Cancer Theragnosis, in Nanoplatform-Based Molecular Imaging (ed X. Chen), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470767047.ch22

Editor Information

  1. 2

    Molecular Imaging Program at Stanford and Bio-X Program, Department of Radiology, Stanford University School of Medicine, Stanford, California, USA

  2. 3

    Laboratory for Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland, USA

Author Information

  1. Biomedical Research Center, Korea Institute of Science and Technology, Seoul, South Korea

Publication History

  1. Published Online: 25 MAY 2011
  2. Published Print: 28 MAR 2011

ISBN Information

Print ISBN: 9780470521151

Online ISBN: 9780470767047



  • multifunctional nanoparticles for cancer theragnosis - a new concept in next-generation cancer treatment, combining early-stage diagnosis and efficient therapy;
  • passive targeting phenomenon, by Maeda and colleagues - “enhanced permeation and retention effect (EPR effect)”;
  • theragnosis, and multifunctional nanoparticles - lack of tumor selectivity, low therapeutic index of imaging probes and therapeutic agents


This chapter contains sections titled:

  • Introduction

  • Concept of Cancer Theragnosis

  • Multifunctional Nanoparticles for Cancer Theragnosis

  • Prospects and Challenges of Cancer Theragnosis

  • References